| Literature DB >> 29045906 |
Colleen S McGary1, Claire Deleage2, Justin Harper1, Luca Micci1, Susan P Ribeiro3, Sara Paganini1, Leticia Kuri-Cervantes3, Clarisse Benne3, Emily S Ryan1, Robert Balderas4, Sherrie Jean1, Kirk Easley5, Vincent Marconi6, Guido Silvestri6, Jacob D Estes2, Rafick-Pierre Sekaly3, Mirko Paiardini7.
Abstract
Antiretroviral therapy (ART) suppresses viral replication in HIV-infected individuals but does not eliminate the reservoir of latently infected cells. Recent work identified PD-1+ follicular helper T (Tfh) cells as an important cellular compartment for viral persistence. Here, using ART-treated, SIV-infected rhesus macaques, we show that CTLA-4+PD-1- memory CD4+ T cells, which share phenotypic markers with regulatory T cells, were enriched in SIV DNA in blood, lymph nodes (LN), spleen, and gut, and contained replication-competent and infectious virus. In contrast to PD-1+ Tfh cells, SIV-enriched CTLA-4+PD-1- CD4+ T cells were found outside the B cell follicle of the LN, predicted the size of the persistent viral reservoir during ART, and significantly increased their contribution to the SIV reservoir with prolonged ART-mediated viral suppression. We have shown that CTLA-4+PD-1- memory CD4+ T cells are a previously unrecognized component of the SIV and HIV reservoir that should be therapeutically targeted for a functional HIV-1 cure.Entities:
Keywords: CTLA-4; HIV; PD-1; SIV; T follicular helper cells; animal models; co-inhibitory receptors; latent viral reservoir; regulatory T cells
Mesh:
Substances:
Year: 2017 PMID: 29045906 PMCID: PMC5679306 DOI: 10.1016/j.immuni.2017.09.018
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745